About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
Quant Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesAster DM Healthcare Limited10.051564219238.5990
Domestic EquitiesRPG Life Sciences Limited9.096115052934.9303
Domestic EquitiesANTHEM BIOSCIENCES LIMITED6.816832000026.1776
Domestic EquitiesZydus Wellness Ltd6.746912834625.9092
Domestic EquitiesSequent Scientific Limited6.5149147712625.0181
Domestic EquitiesPfizer Ltd6.43864795424.7251
Domestic EquitiesAlivus Life Sciences6.059724629823.2702
Domestic EquitiesHDFC Life Insurance Co Ltd5.979329740622.9612
Domestic EquitiesAurobindo Pharma Limited5.816521730022.3363
Domestic EquitiesSMS Pharmaceuticals Limited5.139083321319.7346
Domestic EquitiesMax Healthcare Institute Limited4.249714138116.3196
Domestic EquitiesConcord Biotech Limited3.65558347214.0375
Domestic EquitiesSun Pharmaceutical Industries Limited3.20757724912.3174
Domestic EquitiesLupin Limited2.81155697610.7964
Domestic EquitiesLaxmi Dental Limited2.55232872109.8010
Domestic EquitiesGland Pharma Limited1.3683280765.2544
Total 86.5041 332.1879
Cash & Cash Equivalents and Net AssetsTREPS 01-Sep-2025 DEPO 1010.28713951639.5040
Cash & Cash Equivalents and Net AssetsNCA-NET CURRENT ASSETS-13.2654 -50.9409
Total -2.9783 -11.4369
Treasury Bills91 Days Treasury Bill 18-Sep-20251.03874000003.9888
Treasury Bills91 Days Treasury Bill 25-Sep-20250.77823000002.9885
Treasury Bills91 Days Treasury Bill 20-Nov-20250.77173000002.9635
Treasury Bills91 Days Treasury Bill 28-Nov-20250.77083000002.9600
Treasury Bills91 Days Treasury Bill 11-Sep-20250.51992000001.9964
Treasury Bills182 Days Treasury Bill 04-Sep-20250.26021000000.9993
Treasury Bills91 Days Treasury Bill 04-Sep-20250.26021000000.9993
Total 4.3998 16.8958
Derivatives-FuturesLupin Limited 30/09/20256.521913132525.0450
Derivatives-FuturesSun Pharmaceutical Industries Limited 30/09/20253.03347280011.6487
Derivatives-FuturesAurobindo Pharma Limited 30/09/20252.5190935009.6735
Total 12.0744 46.3672
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.